Search Weight Loss Topics:




Jun 24

BRIEF-Novo Nordisk says trial shows semaglutide helps to lose weight – Reuters

June 23 Novo Nordisk

* Reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial

* Says in the trial, 957 people with obesity were randomised to treatment with doses of semaglutide between 0.05 to 0.4 mg/day or placebo

* Says from a mean baseline weight of around 111 kg and a body mass index of approximately 39 kg/m(2), a weight loss up to 17.8 kg was observed after 52 weeks of treatment with semaglutide

* Says this corresponded to an estimated 13.8% weight loss compared to the weight loss of 2.3% achieved by diet, exercise and placebo alone, with all treatment arms adjusted for people discontinuing treatment in the study

* Says expects phase 3 programme with semaglutide to begin in 2018 Source text for Eikon: Further company coverage:

* Trump: "I think we're going to get there" (Adds health sector stocks and Trump quote)

June 23 Anthem Inc, the largest U.S. health insurance company, has agreed to settle litigation over hacking in 2015 that compromised about 79 million people's personal information for $115 million, which lawyers said would be the largest settlement ever for a data breach.

Follow this link:
BRIEF-Novo Nordisk says trial shows semaglutide helps to lose weight - Reuters

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker